ID   NR4A1_MOUSE             Reviewed;         601 AA.
AC   P12813;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   07-APR-2021, entry version 202.
DE   RecName: Full=Nuclear receptor subfamily 4 group A member 1;
DE   AltName: Full=Nuclear hormone receptor NUR/77;
DE   AltName: Full=Nuclear protein N10;
DE   AltName: Full=Orphan nuclear receptor HMR;
GN   Name=Nr4a1; Synonyms=Gfrp, Hmr, N10, Nur77;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3186734; DOI=10.1073/pnas.85.22.8444;
RA   Hazel T.G., Nathans D., Lau L.F.;
RT   "A gene inducible by serum growth factors encodes a member of the steroid
RT   and thyroid hormone receptor superfamily.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:8444-8448(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND SUBCELLULAR LOCATION.
RC   TISSUE=Kidney, and Liver;
RX   PubMed=2555161; DOI=10.1002/j.1460-2075.1989.tb08494.x;
RA   Ryseck R.P., Macdonald-Bravo H., Mattei M.-G., Ruppert S., Bravo R.;
RT   "Structure, mapping and expression of a growth factor inducible gene
RT   encoding a putative nuclear hormonal binding receptor.";
RL   EMBO J. 8:3327-3335(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=22427340; DOI=10.1161/circresaha.111.258814;
RA   Papac-Milicevic N., Breuss J.M., Zaujec J., Ryban L., Plyushch T.,
RA   Wagner G.A., Fenzl S., Dremsek P., Cabaravdic M., Steiner M., Glass C.K.,
RA   Binder C.J., Uhrin P., Binder B.R.;
RT   "The interferon stimulated gene 12 inactivates vasculoprotective functions
RT   of NR4A nuclear receptors.";
RL   Circ. Res. 110:E50-E63(2012).
CC   -!- FUNCTION: Orphan nuclear receptor. May act concomitantly with NURR1 in
CC       regulating the expression of delayed-early genes during liver
CC       regeneration. Binds the NGFI-B response element (NBRE) 5'-AAAAGGTCA-3'.
CC       May inhibit NF-kappa-B transactivation of IL2. Participates in energy
CC       homeostasis by sequestrating the kinase STK11 in the nucleus, thereby
CC       attenuating cytoplasmic AMPK activation (By similarity). Plays a role
CC       in the vascular response to injury (PubMed:22427340). {ECO:0000250,
CC       ECO:0000269|PubMed:22427340}.
CC   -!- SUBUNIT: Binds DNA as a monomer (By similarity). Interacts with
CC       GADD45GIP1. Interacts with STK11 (By similarity). Interacts with IFI27
CC       (By similarity). Heterodimer (via DNA-binding domain) with RXRA (via C-
CC       terminus); DNA-binding of the heterodimer is enhanced by 9-cis retinoic
CC       acid (By similarity). Competes for the RXRA interaction with EP300 and
CC       thereby attenuates EP300 mediated acetylation of RXRA (By similarity).
CC       {ECO:0000250|UniProtKB:P22736, ECO:0000250|UniProtKB:P22829}.
CC   -!- INTERACTION:
CC       P12813; Q8VHR5: Gatad2b; NbExp=2; IntAct=EBI-10896863, EBI-3043880;
CC       P12813; Q9R190: Mta2; NbExp=2; IntAct=EBI-10896863, EBI-904134;
CC       P12813; Q7TPV4: Mybbp1a; NbExp=3; IntAct=EBI-10896863, EBI-1373622;
CC       P12813; Q9DBD5: Pelp1; NbExp=3; IntAct=EBI-10896863, EBI-6909114;
CC       P12813; Q04207: Rela; NbExp=2; IntAct=EBI-10896863, EBI-644400;
CC       P12813; Q62318: Trim28; NbExp=3; IntAct=EBI-10896863, EBI-346909;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:2555161}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P22736}. Mitochondrion
CC       {ECO:0000250|UniProtKB:P22736}. Note=Nuclear export to the cytoplasm is
CC       XPO1-mediated and positively regulated by IFI27. Translocation to the
CC       mitochondrion upon interaction with RXRA and upon the presence of 9-cis
CC       retinoic acid (By similarity). {ECO:0000250|UniProtKB:P22736}.
CC   -!- TISSUE SPECIFICITY: Highest levels occur in the testis followed by
CC       brain and muscle tissue.
CC   -!- DEVELOPMENTAL STAGE: Highest levels are found in the adult with barely
CC       detectable levels in pre- and early postnatal tissue.
CC   -!- INDUCTION: By serum growth factors and during liver regeneration.
CC   -!- PTM: Phosphorylated at Ser-354 by RPS6KA1 and RPS6KA3 in response to
CC       mitogenic or stress stimuli. {ECO:0000250}.
CC   -!- PTM: Acetylated by p300/CBP, acetylation increases stability.
CC       Deacetylated by HDAC1 (By similarity). {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Homozygous knockout mice display restenosis, the
CC       narrowing of blood vessels upon vascular injury.
CC       {ECO:0000269|PubMed:22427340}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR4
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J04113; AAA39843.1; -; mRNA.
DR   EMBL; X16995; CAA34862.1; -; Genomic_DNA.
DR   EMBL; X60132; CAA42718.1; -; mRNA.
DR   EMBL; BC004770; AAH04770.1; -; mRNA.
DR   CCDS; CCDS27848.1; -.
DR   PIR; S06953; QRMSN1.
DR   RefSeq; NP_034574.1; NM_010444.2.
DR   RefSeq; XP_006520518.1; XM_006520455.1.
DR   RefSeq; XP_006520519.1; XM_006520456.1.
DR   RefSeq; XP_006520521.1; XM_006520458.1.
DR   RefSeq; XP_006520522.1; XM_006520459.3.
DR   RefSeq; XP_017171925.1; XM_017316436.1.
DR   SMR; P12813; -.
DR   BioGRID; 200346; 8.
DR   CORUM; P12813; -.
DR   DIP; DIP-61643N; -.
DR   ELM; P12813; -.
DR   IntAct; P12813; 16.
DR   STRING; 10090.ENSMUSP00000023779; -.
DR   ChEMBL; CHEMBL3308901; -.
DR   iPTMnet; P12813; -.
DR   PhosphoSitePlus; P12813; -.
DR   PaxDb; P12813; -.
DR   PRIDE; P12813; -.
DR   ProteomicsDB; 295525; -.
DR   Antibodypedia; 14466; 705 antibodies.
DR   Ensembl; ENSMUST00000023779; ENSMUSP00000023779; ENSMUSG00000023034.
DR   Ensembl; ENSMUST00000228985; ENSMUSP00000155225; ENSMUSG00000023034.
DR   GeneID; 15370; -.
DR   KEGG; mmu:15370; -.
DR   UCSC; uc007xsv.2; mouse.
DR   CTD; 3164; -.
DR   MGI; MGI:1352454; Nr4a1.
DR   eggNOG; KOG4217; Eukaryota.
DR   GeneTree; ENSGT00950000183038; -.
DR   HOGENOM; CLU_007368_14_2_1; -.
DR   InParanoid; P12813; -.
DR   OMA; QKNSKYV; -.
DR   OrthoDB; 454476at2759; -.
DR   PhylomeDB; P12813; -.
DR   TreeFam; TF315430; -.
DR   Reactome; R-MMU-198693; AKT phosphorylates targets in the nucleus.
DR   Reactome; R-MMU-383280; Nuclear Receptor transcription pathway.
DR   BioGRID-ORCS; 15370; 4 hits in 52 CRISPR screens.
DR   ChiTaRS; Gchfr; mouse.
DR   PRO; PR:P12813; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   RNAct; P12813; protein.
DR   Bgee; ENSMUSG00000023034; Expressed in adrenal gland and 286 other tissues.
DR   ExpressionAtlas; P12813; baseline and differential.
DR   Genevisible; P12813; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0031965; C:nuclear membrane; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005667; C:transcription regulator complex; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; IDA:BHF-UCL.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:MGI.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0035259; F:glucocorticoid receptor binding; ISO:MGI.
DR   GO; GO:0004879; F:nuclear receptor activity; IEA:InterPro.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:MGI.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:MGI.
DR   GO; GO:0008134; F:transcription factor binding; ISO:MGI.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006915; P:apoptotic process; IMP:MGI.
DR   GO; GO:0002042; P:cell migration involved in sprouting angiogenesis; ISO:MGI.
DR   GO; GO:0071376; P:cellular response to corticotropin-releasing hormone stimulus; IDA:UniProtKB.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; ISO:MGI.
DR   GO; GO:0071310; P:cellular response to organic substance; IDA:MGI.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISO:MGI.
DR   GO; GO:0035767; P:endothelial cell chemotaxis; ISO:MGI.
DR   GO; GO:0045444; P:fat cell differentiation; IDA:UniProtKB.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:MGI.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; ISO:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0061469; P:regulation of type B pancreatic cell proliferation; ISS:UniProtKB.
DR   GO; GO:0051602; P:response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0010035; P:response to inorganic substance; ISO:MGI.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IMP:MGI.
DR   Gene3D; 1.10.565.10; -; 1.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR003071; Nuc_orp_HMR_rcpt.
DR   InterPro; IPR003070; Nuc_orph_rcpt.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01285; HMRNUCRECPTR.
DR   PRINTS; PR01284; NUCLEARECPTR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; DNA-binding; Metal-binding; Mitochondrion; Nucleus;
KW   Phosphoprotein; Receptor; Reference proteome; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..601
FT                   /note="Nuclear receptor subfamily 4 group A member 1"
FT                   /id="PRO_0000053716"
FT   DOMAIN          363..598
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        267..342
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         270..290
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         306..330
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          173..469
FT                   /note="Required for nuclear import"
FT                   /evidence="ECO:0000250|UniProtKB:P22736"
FT   REGION          302..364
FT                   /note="Required for the interaction with RXRA"
FT                   /evidence="ECO:0000250|UniProtKB:P22736"
FT   COMPBIAS        83..94
FT                   /note="Poly-Ser"
FT   COMPBIAS        186..190
FT                   /note="Poly-Pro"
FT   COMPBIAS        586..589
FT                   /note="Poly-Pro"
FT   MOD_RES         344
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P22829"
FT   MOD_RES         354
FT                   /note="Phosphoserine; by PKA, RPS6KA1 and RPS6KA3"
FT                   /evidence="ECO:0000250|UniProtKB:P22829"
FT   CONFLICT        45
FT                   /note="A -> T (in Ref. 2; CAA42718)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   601 AA;  64738 MW;  8CFF45B58253887B CRC64;
     MPCIQAQYGT PATSPGPRDH LTGDPLALEF GKPTMDLASP ETAPAAPATL PSFSTFMDGY
     TGEFDTFLYQ LPGTTQPCSS ACSSASSTSS SSSSATSPAS ASFKFEDFQV YGCYPGTLSG
     PLDETLSSSG SEYYGSPCSA PSPSTPNFQP SQLSPWDGSF GHFSPSQTYE GLWAWTEQLP
     KASSGPPPPP TFFSFSPPTG PSPSLAQSSL KLFPPPATHQ LGEGESYSMP AAFPGLAPTS
     PNRDTSGILD APVTSTKSRS GASGGSEGRC AVCGDNASCQ HYGVRTCEGC KGFFKRTVQK
     SAKYICLANK DCPVDKRRRN RCQFCRFQKC LAVGMVKEVV RTDSLKGRRG RLPSKPKQPP
     DASPTNLLTS LIRAHLDSGP STAKLDYSKF QELVLPRFGK EDAGDVQQFY DLLSGSLDVI
     RKWAEKIPGF IELCPGDQDL LLESAFLELF ILRLAYRSKP GEGKLIFCSG LVLHQLQCAR
     GFGDWIDNIL AFSRSLHSLG VDVPAFACLS ALVLITDRHG LQDPRRVEEL QNRIASCLKE
     HMATVAGDPQ PASCLSRLLG KLPELRTLCT QGLQRIFCLK LEDLVPPPPI VDKIFMDTLS
     F
//
